Apigenin Loaded Lipoid–PLGA–TPGS Nanoparticles for Colon Cancer Therapy: Characterization, Sustained Release, Cytotoxicity, and Apoptosis Pathways
Open Access
Abstract
Colon cancer (CC) is one of major causes of mortality and affects the socio-economic status world-wide. Therefore, developing a novel and efficient delivery system is needed for CC management. Thus, in the present study, lipid polymer hybrid nanoparticles of apigenin (LPHyNPs) was prepared and characterized on various parameters such as particle size (234.80 ± 12.28 nm), PDI (0.11 ± 0.04), zeta potential (−5.15 ± 0.70 mV), EE (55.18 ± 3.61%), etc. Additionally, the DSC, XRD, and FT-IR analysis determined drug entrapment and affinity with the selected excipient, demonstrating a promising drug affinity with the lipid polymer. Morphological analysis via SEM and TEM exhibited spherical NPs with a dark color core, which indicated drug entrapment inside the core. In vitro release study showed significant (p < 0.05) sustained release of AGN from LPHyNPs than AGN suspension. Further, the therapeutic efficacy in terms of apoptosis and cell cycle arrest of developed LPHyNPs against CC was estimated by performing flow cytometry and comparing its effectiveness with blank LPHyNPs and AGN suspension, which exhibited remarkable outcomes in favor of LPHyNPs. Moreover, the mechanism behind the anticancer attribute was further explored by estimating gene expression of various signaling molecules such as Bcl-2, BAX, NF-κB, and mTOR that were involved in carcinogenic pathways, which indicated significant (p < 0.05) results for LPHyNPs. Moreover, to strengthen the anticancer potential of LPHyNPs against chemoresistance, the expression of JNK and MDR-1 genes was estimated. Outcomes showed that their expression level reduced appreciably when compared to blank LPHyNPs and AGN suspension. Hence, it can be concluded that developed LPHyNPs could be an efficient therapeutic system for managing CC.Keywords
Funding Information
- Ministry of Education in Saudi Arabia (IFPRC-189-166-2020)
This publication has 47 references indexed in Scilit:
- Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersionInternational Journal of Nanomedicine, 2014
- The 2 Faces of JNK Signaling in CancerGenes & Cancer, 2013
- FTIR, 1H NMR and EPR spectroscopy studies on the interaction of flavone apigenin with dipalmitoylphosphatidylcholine liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2013
- Biopharmaceutics classification and intestinal absorption study of apigeninInternational Journal of Pharmaceutics, 2012
- Self-assembly nanoparticles for the delivery of bisphosphonates into tumorsInternational Journal of Pharmaceutics, 2011
- Regulation of Mammalian Target of Rapamycin Activity in PTEN-Inactive Prostate Cancer Cells by IκB Kinase αCancer Research, 2007
- Apoptosis and colorectal cancerGut, 2004
- Apoptosis in cancerCarcinogenesis, 2000
- MDR1/P-glycoprotein expression in colorectal cancerEuropean Journal of Cancer, 1995
- Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinolCarcinogenesis, 1986